Read article Prostate cancer - A to Z
This page links to content about prostate cancer.
Prostate cancer is the most common cancer in men in the UK, with more than 34,000 cases diagnosed every year.
A man’s risk of getting prostate cancer increases with age. The cancer is rare in men under 50 but by the age of 80, more than half of all men have cancerous changes in their prostate. But prostate cancer often grows very slowly, meaning that many men may never know they have the disease and will die of unrelated causes.
Or find out more using the links below.
Browse content about Prostate cancer
- Cancer incidence projections for selected cancers
- Dr David Waugh
- November 2010 podcast transcript
- Our progress and achievements in the 1990s
- Prof David Neal
- Prof Gareth Williams
- Professor Ara Darzi
- Professor Ros Eeles
- Prostate cancer Key Facts
- Prostate cancer mortality statistics
- Prostate cancer risk factors
- Prostate cancer survival statistics
Latest Prostate cancer news from Cancer Research UK
- Press Release: Prostate cancer lifetime risk trebles in 25 years
23 January 2013 - Press Release: World-first tissue study could re-shape future of advanced prostate cancer treatment
20 December 2012 - News story: Radiotherapy after surgery slows progress of 'high-risk' prostate cancer
19 October 2012 - Press Release: Stop-start hormone therapy better than continual hormone therapy for prostate cancer
6 September 2012 - Press Release: Scientists solve key piece of prostate cancer puzzle
13 August 2012 - News story: Trial drug extends life of men with advanced prostate cancer
1 June 2012 - Press Release: Protein could be specific marker for prostate cancer
30 May 2012 - News story: Genetic variation 'predicts behaviour of prostate cancer'
8 May 2012 - News story: Sound-wave therapy for prostate cancer may reduce side effects
17 April 2012 - News story: International consortium releases cancer gene data
15 March 2012
- News story: Israeli researchers developing BRCA 'radiation' test
22 January 2013 - Press Release: Personalised prostate cancer screening may save thousands from unnecessary treatment
5 November 2012 - News story: 'Gene barcode' blood test can predict aggressive prostate cancers
9 October 2012 - News story: Trial confirms benefit of 'exciting' new drug for advanced prostate cancer
16 August 2012 - Press Release: ‘Master switch’ experimental drug could treat different cancers
10 July 2012 - Press Release: Cancer Research UK initiative attracts innovative targeted cancer trials to the UK
31 May 2012 - News story: NICE recommends prostate cancer drug abiraterone
16 May 2012 - Press Release: Prostate cancer cases hit 40,000 for the first time
4 May 2012 - Press Release: Scientists uncover route to tumour's energy supply
22 March 2012 - News story: 'Unanswered questions' over PSA prostate screening despite 11-year follow-up of trial
14 March 2012
Related documents
Related audio and video
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Increase text size
Decrease text size
Print pageOn CancerHelp UK
Fast fact
In 1938, our scientists developed the first synthetic female hormone, diethylstilboestrol. It became the treatment of choice for over 40 years for advanced prostate cancer.